Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HCW Biologics (HCWB) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for HCW Biologics (HCWB) over the last 5 years, with Q3 2025 value amounting to 37.47%.

  • HCW Biologics' Return on Capital Employed fell 484600.0% to 37.47% in Q3 2025 from the same period last year, while for Sep 2025 it was 37.47%, marking a year-over-year decrease of 484600.0%. This contributed to the annual value of 116.17% for FY2024, which is 1170600.0% up from last year.
  • As of Q3 2025, HCW Biologics' Return on Capital Employed stood at 37.47%, which was down 484600.0% from 16.35% recorded in Q2 2025.
  • HCW Biologics' 5-year Return on Capital Employed high stood at 23.93% for Q4 2024, and its period low was 37.47% during Q3 2025.
  • Its 5-year average for Return on Capital Employed is 3.33%, with a median of 0.49% in 2023.
  • Per our database at Business Quant, HCW Biologics' Return on Capital Employed surged by 250300bps in 2024 and then tumbled by -484600bps in 2025.
  • HCW Biologics' Return on Capital Employed (Quarter) stood at 0.25% in 2021, then dropped by -29bps to 0.33% in 2022, then plummeted by -237bps to 1.1% in 2023, then surged by 2269bps to 23.93% in 2024, then plummeted by -257bps to 37.47% in 2025.
  • Its Return on Capital Employed was 37.47% in Q3 2025, compared to 16.35% in Q2 2025 and 21.41% in Q1 2025.